|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Molecular Genetics |
Departments of Pathology (N.A., R.N.W., R.E.M., D.D.B., S.H.B) and Surgery (H.S.F.), Duke University Medical Center, Durham, NC 27710; Tumor Genetics and Molecular Cytogenetics, Institute for Molecular Biotechnology, Beutenbergstrasse 11, 07745 Jena, Germany (E.S.); National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892 (A.D.)
2 Address correspondence and reprint requests to Sandra H. Bigner, Duke University Medical Center, Department of Pathology, P.O. Box 3712, Durham, NC 27710.
Abstract
Cell lines and xenografts derived from medulloblastomas are useful tools to investigate the chromosomal changes in these tumors. Here we used G-banding, fluorescence in situ hybridization (FISH), spectral karyotyping (SKY), and comparative genomic hybridization to study 4 medulloblastoma cell lines and 1 xenograft. Cell line D-425 Med had a relatively simple karyotype, with a terminal deletion of 10q and amplification of MYC in double-minutes (dmins). FISH demonstrated that an apparent isochromosome (17q) by routine karyotyping was actually an unbalanced translocation between 2 copies of chromosome 17. Cell line D-556 Med also had a simple near-diploid stemline with an unbalanced 1;13 translocation resulting in a gain of 1q, an isochromosome (17q), and dmins. These findings were initially described using routine G-banded preparations, and FISH showed that the dmins were an amplification of MYC and the i(17q) was an isodicentric 17q chromosome. The other finding was confirmed by FISH, SKY, and comparative genomic hybridization. Cell lines D-721 Med and D-581 Med had complex karyotypic patterns that could be completely characterized only when FISH and SKY were used. Xenograft D-690 Med also had a complex pattern that FISH and SKY were helpful in completely elucidating. Interestingly, balanced reciprocal translocations were seen as well as complicated unbalanced translocations and marker chromosomes. Comparative genomic hybridization demonstrated only a deletion of 10q22-10q24, supporting the idea that despite the complexity of the chromosomal rearrangements, minimal alterations in the overall chromosomal content had occurred. This study demonstrates that routine cytogenetic preparations are adequate to describe chromosomal abnormalities in occasional medulloblastoma samples, but a broader spectrum of molecular cytogenetic methods is required to completely analyze most of these tumor samples.
References
Adinolfi, M., and Davies, A.F. (1994) Non-Isotopic In Situ Hybridization: Applications to Clinical Diagnosis and Molecular Genetics. Austin: R.G. Landes.
Aldosari, N., Rasheed, B.K.A., McLendon, R.E., Friedman, H.S., Bigner, D.D., and Bigner, S.H. (2000) Characterization of chromosome 17 abnormalities in medulloblastomas. Acta Neuropathol. 99,345 -351.[CrossRef][Medline]
Bigner, S.H., and Schrock, E. (1997) Molecular cytogenetics of brain tumors. J. Neuropathol. Exp. Neurol. 56,1173 -1181.[Web of Science][Medline]
Bigner, S.H., and Vogelstein, B. (1990) Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol. 1,12 -18.[Medline]
Bigner, S.H., Mark, J., Friedman, H.S., Biegel, J.A., and Bigner, D.D. (1988) Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet. Cytogenet. 30, 91-101.[CrossRef][Web of Science][Medline]
Bigner, S.H., Friedman, H.S., Vogelstein, B., Oakes, W.J., and
Bigner, D.D. (1990) Amplification of the c-myc gene in human
medulloblastoma cell lines and xenografts. Cancer Res.
50,2347
-2350.
Bigner, S.H., McLendon, R.E., Fuchs, H., McKeever, P.E., and Friedman, H.S. (1997) Chromosomal characteristics of childhood brain tumors. Cancer Genet. Cytogenet. 97,125 -134.[CrossRef][Web of Science][Medline]
Friedman, H.S., Bigner, S.H., McComb, R.D., Schold, S.C., Jr., Pasternak, J.F., Groothuis, D.R., and Bigner, D.D. (1983) A model for human medulloblastoma: Growth, morphology, and chromosomal analysis in vitro and in athymic mice. J. Neuropathol. Exp. Neurol. 42,485 -503.[Web of Science][Medline]
Giangaspero, F., Bigner, S.H., Kleihues, P., Pietsch, T., and Trojanowski, J.Q. (2000) Medulloblastoma. In: Kleihues,P., and Cavenee, W.K. (Eds.), Pathology and Genetics of Tumours of the Nervous System: World Health Organization Classification of Tumors. Lyon, France: IARC Press. pp.129 -137.
Gozzetti, A., and Le Beau, M.M. (2000) Fluorescence in situ hybridization: Uses and limitations. Semin. Hematol. 37,320 -333.[CrossRef][Web of Science][Medline]
Grant, G., Pathak, S., and Maria, B.L. (1988) Identification of marker chromosomes in a human medulloblastoma cell line (D283 Med). Cancer Genet. Cytogenet. 34,247 -250.[CrossRef][Web of Science][Medline]
Jay, V., Squire, J., Bayani, J., Alkhani, A.M., Rutka, J.T., and Zielenska, M. (1999) Oncogene amplification in medulloblastoma: Analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization. Pathology 31,337 -344.[CrossRef][Web of Science][Medline]
Kallioniemi, A., Kallioniemi, O.P., Sudar, D., Rutovitz, D., Gray,
J.W., Waldman, F., and Pinkel, D. (1992) Comparative genomic
hybridization for molecular cytogenetic analysis of solid tumors.
Science 258,818
-821.
Keles, G.E., Berger, M.S., Srinivasan, J., Kolstoe, D.D., Bobola, M.S., and Silber, J.R. (1995) Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol. Res. 7,493 -503.[Web of Science][Medline]
Lichter, P., Joos, S., Bentz, M., and Lampel, S. (2000) Comparative genomic hybridization: Uses and limitations. Semin. Hematol. 37,348 -357.[CrossRef][Web of Science][Medline]
Lopez-Gines, C., Cerda-Nicolas, M., Gil-Benso, R., Barcia-Salorio, J.L., and Llombart-Bosch, A. (1997) Involvement of the long arm of chromosome 9 in medulloblastoma in an adult. Cancer Genet. Cytogenet. 96,81 -84.[CrossRef][Web of Science][Medline]
McDonald, J.D., Daneshvar, L., Willert, J.R., Matsumura, K., Waldman, F., and Cogen, P.H. (1994) Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23,229 -232.[CrossRef][Web of Science][Medline]
Mitelman, F. (Ed.) (1995) ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger.
Reardon, D.A., Michalkiewicz, E., Boyett, J.M., Sublett, J.E.,
Entrekin, R.E., Ragsdale, S.T., Valentine, M.B., Behm, F.G., Li, H., Heideman,
R.L., Kun, L.E., Shapiro, D.N., and Look, A.T. (1997) Extensive
genomic abnormalities in childhood medulloblastoma by comparative genomic
hybridization. Cancer Res.
57,4042
-4047.
Sawyer, J.R., Swanson, C.M., Roloson, G.J., Longee, D.C., Boop, F.A., and Chadduck, W.M. (1991) Molecular cytogenetic analysis of a medulloblastoma with isochromosome 17 and double minutes. Cancer Genet. Cytogenet. 57,181 -186.[CrossRef][Web of Science][Medline]
Schrock, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M.A., Ning, Y., Ledbetter, D.H., Bar-Am, I., Soenksen, D., Garini, Y., and Ried, T. (1996) Multicolor spectral karyotyping of human chromosomes. Science 273,494 -497.[Abstract]
Schrock, E., and Padilla-Nash, H. (2000) Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin. Hematol. 37,334 -347.[CrossRef][Web of Science][Medline]
Steichen-Gersdorf, E., Baumgartner, M., Kreczy, A., Maier, H., and Fink, F.M. (1997) Deletion mapping on chromosome 17p in medulloblastoma. Br. J. Cancer 76,1284 -1287.[Web of Science][Medline]
Stratton, M.R., Darling, J., Cooper, C.S., and Reeves, B.R. (1991) A case of cerebellar medulloblastoma with a single chromosome abnormality. Cancer Genet. Cytogenet. 53,101 -103.[CrossRef][Web of Science][Medline]
Thein, A., Trkova, M., Fox, M., and Parrington, J. (2000) The application of comparative genomic hybridization to previously karyotyped cervical cancer cell lines. Cancer Genet. Cytogenet. 116,59 -65.[CrossRef][Web of Science][Medline]
Tomlinson, F.H., Jenkins, R.B., Scheithauer, B.W., Keelan, P.A., Ritland, S., Parisi, J.E., Cunningham, J., and Olsen, K.D. (1994) Aggressive medulloblastoma with high-level N-myc amplification. Mayo Clinic Proc. 69,359 -365.[Web of Science][Medline]
Vagner-Capodano, A.M., Zattara-Cannoni, H., Gambarelli, D., Gentet, J.C., Genitori, L., Lena, G., Graziani, N., Raybaud, C., Choux, M., and Grisoli, F. (1994) Detection of i(17q) chromosome by fluorescent in situ hybridization (FISH) with interphase nuclei in medulloblastoma. Cancer Genet. Cytogenet. 78, 1-6.[CrossRef][Web of Science][Medline]
Wiltshire, R.N., Rasheed, B.K.A., Friedman, H.S., Friedman, A.H., and Bigner, S.H. (2000) Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification. Neuro-Oncology [serial online], Doc. 00-015, June 20, 2000. URL http://neuro-oncology.mc.duke.edu. Neuro-Oncology 2,164 -173.[Abstract]
Wiltshire, R.N., Dennis, T.R., Sondak, V.K., Meltzer, P.S., and Trent, J.M. (2001) Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. Cancer Genet. Cytogenet. 131,97 -103.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Boon, C. G. Eberhart, and G. J. Riggins Genomic Amplification of Orthodenticle Homologue 2 in Medulloblastomas Cancer Res., February 1, 2005; 65(3): 703 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Di, S. Liao, D. C. Adamson, T. J. Parrett, D. K. Broderick, Q. Shi, C. Lengauer, J. M. Cummins, V. E. Velculescu, D. W. Fults, et al. Identification of OTX2 as a Medulloblastoma Oncogene Whose Product can be Targeted by All-Trans Retinoic Acid Cancer Res., February 1, 2005; 65(3): 919 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I-M. Siu, A. Lal, J. R. Blankenship, N. Aldosari, and G. J. Riggins c-Myc Promoter Activation in Medulloblastoma Cancer Res., August 15, 2003; 63(16): 4773 - 4776. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
